Endologix Receives Approval to Launch Powerlink System in Japan
Posted on: Tuesday, 12 February 2008, 09:01 CST
Endologix has received Shonin approval from the Japanese Ministry of Health, Labour and Welfare and the company will soon be initiating Powerlink System product shipments to Japan.
Endologix's Powerlink System is an endoluminal stent graft for treating abdominal aortic aneurysms.
Paul McCormick, president and CEO of Endologix, said: "We will begin by shipping an initial stocking order in February to our Japanese distributor Cosmotec and expect that the first Powerlink System implants will be performed at the Tokyo Medical University Hospital."
Source: Datamonitor
Related Articles
- Favorable Endologix Powerlink XL System Clinical Data to Be Announced November 20 at Veith Symposium
- Endologix Announces FDA Approval of IntuiTrak, an Innovative New Delivery System for the Powerlink AAA Device
- Six-Year Follow-Up Data Confirms Endologix Powerlink's Outstanding Durability and Outcomes
- First Commercial Procedures Performed in Japan With Endologix Powerlink System
- Endologix Launches the Powerlink System in Japan
- Endologix Completes Enrollment in Powerlink Trial With 34 Millimeter Diameter Infrarenal Cuff
- Endologix Provides Japanese Approval Update for Powerlink System
- Endologix Announces Favorable Powerlink Five-Year Follow-Up Data at TCT 2006 Conference
- Endologix Approved to Manufacture Powerlink System at New Facility
Rating: 3.7 / 5 (12 votes)
 |
 |
Rate this article:
User Comments (0)
RSS Feeds